Company

Building a Company Around Responsible Medical Innovation

Marrian Technologies was formed to bridge the distance between medical invention and future real-world implementation.

The company combines the knowledge of the technology's original pioneers with leadership focused on strategy, health, risk, operations, partnerships, and responsible commercialization.

Mission

To Pioneer the Responsible Commercialization of Medical Innovation—From the Lab to the Patient.

Marrian Technologies' objective is to create and improve technologies that may eventually help people heal faster and experience fewer complications, while maintaining a disciplined commitment to safety, evidence, accessibility, ethical leadership, and responsible development.

The company's role is to bridge promising scientific invention and the disciplined, multidisciplinary work required to bring medical innovation toward future clinical and commercial application—built around the original pioneers, an emerging collaborative ecosystem, and a long-term commitment to patient impact.

Founding Story

Why Marrian Technologies Was Formed

Marrian Technologies was formed in 2026 to explore and advance the commercial potential of an integrated wound-care innovation.

The company is currently building the organizational, technical, regulatory, and commercial foundation required to support the technology's continued development.

Current efforts include strengthening engagement with the original inventors, defining the development pathway, evaluating clinical and market needs, building a funding strategy, establishing company operations, and developing relationships with potential research, government, clinical, and industry partners.

Stage Context

What "Early-Stage and Studio-Supported" Means

Marrian Technologies is a pre-funding California C-Corporation in the company-building and technology-development stage. The company is not commercially operational, does not have a product available for sale, and has not completed clinical validation or received regulatory clearance.

"Studio-supported" reflects the company-building and commercialization support Marrian is exploring through external programs and relationships. References to external organizations should not be interpreted as investment, endorsement, sponsorship, procurement, regulatory approval, or formal institutional partnership unless expressly confirmed.

Current Focus

  • Strengthening engagement with the original inventors
  • Defining the technical and regulatory development pathway
  • Building a funding and grant strategy
  • Establishing initial company operations and compliance foundation
  • Developing research, clinical, government, and industry relationships

A fuller view of company-building priorities appears below.

Executive Leadership

The Founders

Brian Jones

Co-founder and Chief Executive Officer

Brian brings a robust background in regulatory frameworks, risk management, and clinical workflow translation to Marrian Medical Technologies. He leads the company's commercialization strategy and Department of War translation efforts, drawing on experience in EHS regional management, risk and compliance strategy, and direct clinical work as an ophthalmic assistant. He holds an MPH in Health Science and a B.S. in Kinesiology from California State University, San Marcos.

Mark Sowell

Co-founder and Chief Operating Officer

Mark combines more than a decade of hands-on clinical diagnostics experience with advanced technical expertise in data science, machine learning architectures, and cellular/molecular biology. He leads Marrian Medical Technologies' operational execution, product definition, and the data pipeline that translates wound imaging and therapy telemetry into structured, clinically meaningful signals. He holds an M.S. in Data Science.

Board of Directors

The Pioneers Behind the Technology

The original pioneers of Marrian Technologies' wound-care concept remain involved in its continued advancement and serve on the company's Board of Directors.

Dr. Sidney Johnson

Technology Pioneer · Board Member

Biography to be added

Dr. Russell Woo

Technology Pioneer · Board Member

Biography to be added

Professor Scott Miller, PhD

Technology Pioneer · Board Member

Biography to be added

Principles

Principles That Guide the Company

Compassion

Marrian Technologies approaches medical innovation through the experiences of patients, caregivers, clinicians, and communities. Human need remains central to how the company evaluates technology and future impact.

Ethical Leadership

The company seeks to pursue science, partnerships, funding, and commercialization with integrity, transparency, and accountability.

Innovation

Marrian Technologies explores evidence-based opportunities to improve both healing technologies and the operational systems that support their responsible development.

Environmental Stewardship

The company intends to consider the environmental effects of materials, manufacturing, logistics, product use, and long-term commercialization decisions.

Safety

Patient well-being is intended to remain foundational to every future technical, clinical, regulatory, and business decision.

At a Glance

Corporate Information

Foundational facts about Marrian Technologies Inc.

Legal name
Marrian Technologies Inc.
Entity type
California C-Corporation
Date formed
February 6, 2026
Headquarters
Sacramento, California
Company stage
Early-stage and pre-funding
Core technology
Proprietary integrated wound-care platform (details confidential)
Industry
Medical technology and wound care
Primary focus
Technology development and responsible commercialization planning
Support model
Studio-supported company development

Company-Building Priorities

Where We Are Focused Today

01Technology development
02Inventor engagement
03Research and validation planning
04Regulatory strategy
05Quality and compliance planning
06Funding development
07Government and dual-use market exploration
08Strategic partnership development
09Future operational and manufacturing planning

Start a Conversation

Reach out to discuss research, clinical collaboration, investment, funding, government opportunities, or strategic partnerships.